What makes catheter ablation stand out for those with AFib?​ - It doesn't rely on medications.(1,4-10)*​ - It’s minimally invasive.​ - It may not require a long recovery period.​ - It may help alleviate in symptoms, improve quality of life(8-10), and reduce of risk of stroke.​ September marks #AFibAwarenessMonth — a time to increase education around progressive and common cardiac disease. Learn more about #AFib and all of your treatment options by visiting ow.ly/terI50ZR5m3.​ #JnJAFibAwarenessMonth​ *AFib is a serious condition, and patients should consult their doctors on a complete picture of the risks and benefits of their AFib treatments. Cardiac catheter ablation may not be right for all patients.​ US_ELP_ALEL_405747​ © Johnson & Johnson and its affiliates 2026 This content is intended for US audiences.

Cardiac ablation experts predict the number of people affected by AFib could increase by more than 60% by 2050, highlighting the critical need for effective treatment options today.4 Discover how advancing radiofrequency ablation (RFA) and pulsed field ablation (PFA) is at the heart of AFib treatment. Read the full article: ow.ly/RFs050ZR5zT #AFibAwarenessMonth *Intended for US audience.

Burnout. It’s a term used to describe the emotional and physical fallout of prolonged exhaustion, stress and overwhelm. In hospitals, operating rooms and doctors’ offices around the world, burnout is a crisis that has long been simmering and creating high-stakes risks for the people—doctors, nurses, advanced practitioners and more—behind patient care. To better understand the people that we serve, we’re committed to listening to surgeons and supporting solutions that will truly help them stay and thrive in the field. Read the full article at the link: ​ow.ly/bAIt50ZQJQI

As we continue investing in digital and data-driven technologies, we’re helping redefine electrophysiology through AI, paving the way for the next chapter of cardiovascular care. Hear insights from @iamthezack

Dr. Rachel Pope, Professor of Obstetrics and Gynecology, shares what it takes to ensure the next generation of surgeons treating obstetric fistula are prepared to meet patient needs. Read more: ow.ly/TuAv50ZPHny

More than 100,000 procedures performed worldwide reflect the growing confidence physicians have in the VARIPULSE™ Platform. The VARIPULSE™ Platform is built on the strength of CARTO and supported by growing evidence that demonstrates its safety and effectiveness, including: •zero strokes, zero coronary spasms and zero deaths1, •a neurovascular event rate of 0.1%1, and •90.5% freedom from AF/AFL/AT at 12 months2 As adoption accelerates globally, we remain focused on advancing the science and shaping the future of pulsed field ablation (PFA). #VARIPULSE #PFA #ePeeps #Electrophysiology References: 1. Porterfield C, et al. Variable Loop Circular Catheter Pulsed Field Ablation in Real World Practice: Low Complication Rates Across Patient and Procedural Characteristics. Presented at: Heart Rhythm Society April 23 26, 2026; Chicago, IL 2. By Kaplan-Meier estimates in patients with paroxysmal AFib. n=1,023. Scherr D, Bessière F, Kronborg MB, et al. Effectiveness of AF Pulsed Field Ablation With a Variable Loop Circular Catheter: 12-Month VARIPURE Results. Europace. Published online April 11, 2026. doi:10.1093/europace/euag082

Converging medical technologies–AI, advanced computing, and integrated hardware–are giving us the ability to transform raw surgical data into a powerful, dynamic clinical asset. This is the dawn of surgical intelligence. Read the full report at the link: ow.ly/kcxh50ZNtlE

Patients are often told, “You’re the strongest advocate for your own health”—especially when facing a journey like AFib.​ We recognize that the path to diagnosis and management can feel isolating, but it doesn’t have to be. Catheter ablation, a minimally invasive procedure, has offered many individuals new hope—especially when medications haven’t provided adequate relief.​ Healthcare professionals: the support, guidance, and information you provide can change lives. Early diagnosis and timely intervention can be transformative, helping patients achieve lasting symptom relief and improved quality of life. Remind your patients that if AFib goes unaddressed, the condition may progress and symptoms become more severe.​ This #AFibAwarenessMonth, let’s equip patients, families, primary care teams, and specialists with the right questions to ask—and open the door to new possibilities in AFib treatment, including catheter ablation.​ Find more information, resources and facts at ow.ly/1ckI50ZM3Ls and encourage proactive conversations.​ Individual results may vary. Final treatment decisions rest with the patient and their healthcare provider. #JnJAFibAwarenessMonth #PatientAdvocacy #EPeeps​ This post is intended for U.S. healthcare professionals US_ELP_ALEL_405747​ © Johnson & Johnson and its affiliates 20256

Great technology starts with understanding the people who use it. Learn more about the human-centered approach shaping OTTAVA™ in our latest MedTech Insights article: ow.ly/TaWE50ZM4gt #OTTAVA #SurgicalRobotics

Do you know the impact of using ICE ultrasound during PFA? Results from a multicenter prospective study of #Afib patients undergoing PFA demonstrated better outcomes when ICE was used to visualize catheter-tissue contact compared to fluoroscopy. Read the full publication in Heart Rhythm to learn more: ow.ly/62QC50ZIVAc Choose NUVISION™ Ultrasound for the visualization your PFA procedures demand. #EP #ePeeps #Electrophysiology #Nuvision This content is intended for US audiences Important information: Prior to use, refer to the instructions for use for indications, contraindications, adverse events, warnings and precautions. Caution: US law restricts this device to sale by or on the order of a physician. #EP #ePeeps #Electrophysiology #EP #Electrophysiology US_ELP_ULTR_420840 © Johnson & Johnson and its affiliates 2026

50 million people worldwide grappling with Afib(1), and 1 in 4 adults over 40 are at risk(2).​ Join us this #AFibAwarenessMonth as we raise awareness of this progressive disease and the minimally invasive treatment options that could be key to managing AFib. If you or someone you know is struggling to manage AFib, there might be options out there. ​ Learn more by visiting: ow.ly/LnPP50ZItb0​ #JnJAFibAwarenessMonth 1.Mensah, G, Foster, V, Murray, C. et al. Global Burden of Cardiovascular Diseases and Risks, 1990- 2022. J Am Coll Cardiol. 2023 Dec, 82 (25) 2350–2473. ow.ly/c7wA50ZItaY 2.Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018:361:k1453. Published 2018 Apr 26. © Johnson & Johnson and its affiliates 2026

Technology is most valuable when it helps surgeons make informed decisions with confidence. That thinking is reflected throughout the design of OTTAVA™, from its architecture to its digital capabilities. Read the full article here: ow.ly/9FY250ZIsKO #OTTAVA #SurgicalRobotics *Intended for US audiences

Long-term data from the DanGer Shock RCT, published in the New England Journal of Medicine, validates the durability of original findings and confirms the survival benefit of Impella CP™ heart pump increases year-over-year. Learn more: ow.ly/HwBh50ZIcH8

Sanjeev Aggarwal M.D., M.B.A., had a long and rewarding career in cardiovascular surgery before joining J&J MedTech. While his day-to-day responsibilities have shifted, his mission—to better the lives of patients around the world—has remained the same. Read more: ow.ly/TugF50ZIoJI

Meaningful innovation starts with listening. Learn how our collaboration with surgeons, clinical teams and hospitals informed the thinking behind OTTAVA™ in our latest MedTech Insights article: ow.ly/eUX150ZGaIx #OTTAVA #SurgicalRobotics

By providing information at critical moments during procedures, robotics can empower surgeons to make even better judgment calls. An alleviation of the mental and physical burden on surgical teams, greater potential for democratization of care, and the delivery of insights that help clinicians hone their craft to promote more positive patient outcomes. Read the newsletter at the link: ​ow.ly/c59W50ZBZWM

The next era of robotic surgery starts by understanding the people using it. Learn how surgeon insights and human-centered design helped shape the thinking behind OTTAVA™ in our latest MedTech Insights article: ow.ly/BlCT50ZC5c3 #OTTAVA #SurgicalRobotics *Intended for US audiences

What a milestone year at the #SRS2026! We're honored to be part of this community dedicated to advancing robotic surgery and improving care for patients and thank the leadership of SRS for continuing to inspire collaboration, education, and progress. Celebrating the launch of OTTAVA alongside so many innovators made this year's meeting especially meaningful. We are proud of our progress in robotics and remain committed to bringing meaningful innovation to the operating room across all surgery. Here's to continuing to shape the future of surgery, together.

What if every surgery could help improve the next? Our latest Future of Digital Surgery report explores the rise of #surgicalintelligence and the opportunity to transform connected surgical data into actionable insight through AI. Based on perspectives from leaders across healthcare, technology, policy, investment, and payer communities, the report examines the opportunities, challenges, and foundations needed to responsibly scale surgical intelligence. Explore the report: ow.ly/BY7P50ZB9YW #DigitalSurgery

Please join Team MONARCH™ at AABIP and attend our lunchtime symposium. We look forward to seeing you there! Sign up for the session: cvent.me/oYng4V